Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Intangibles (2020)

Editas Medicine (EDIT) has disclosed Intangibles for 1 consecutive years, with $5.0 million as the latest value for Q4 2020.

  • On a quarterly basis, Intangibles changed N/A to $5.0 million in Q4 2020 year-over-year; TTM through Dec 2020 was $5.0 million, a N/A change, with the full-year FY2020 number at $5.0 million, changed N/A from a year prior.
  • Intangibles was $5.0 million for Q4 2020 at Editas Medicine, roughly flat from $5.0 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $5.0 million in Q3 2020 to a low of $5.0 million in Q3 2020.